MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,820 Cr | ₹11,910 Cr | ₹9,925 Cr | ₹8,017 Cr | ₹6,737 Cr |
What is the latest Appropriations of MANKIND PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹13,820 Cr |
| Mar2025 | ₹11,910 Cr |
| Mar2024 | ₹9,925 Cr |
| Mar2023 | ₹8,017 Cr |
| Mar2022 | ₹6,737 Cr |
How is Appropriations of MANKIND PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,820 Cr | 16.04 | |
| Mar2025 | ₹11,910 Cr | 20.00 | |
| Mar2024 | ₹9,925 Cr | 23.80 | |
| Mar2023 | ₹8,017 Cr | 19.00 | |
| Mar2022 | ₹6,737 Cr | - | |
Compare Appropriations of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹108,129.6 Cr | 2.9% | 5.4% | -3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.9% |
5.4% |
-3.6% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses